Cazzaniga G - Search Results

1

Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies.

Saitta C, Rebellato S, Bettini LR, Giudici G, Panini N, Erba E, Massa V, Auer F, Friedrich U, Hauer J, Biondi A, Fazio G, Cazzaniga G. Saitta C, et al. Among authors: cazzaniga g. Blood Cancer J. 2022 Jun 2;12(6):88. doi: 10.1038/s41408-022-00683-9. Blood Cancer J. 2022. PMID: 35654786 Free PMC article. No abstract available.

2

Monitoring minimal residual disease using chromosomal translocations in childhood ALL.

Cazzaniga G, Rossi V, Biondi A. Cazzaniga G, et al. Best Pract Res Clin Haematol. 2002 Mar;15(1):21-35. doi: 10.1053/beha.2002.0183. Best Pract Res Clin Haematol. 2002. PMID: 11987914 Review.

3

Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response.

Cazzaniga G, Lanciotti M, Rossi V, Di Martino D, Aricò M, Valsecchi MG, Basso G, Masera G, Micalizzi C, Biondi A. Cazzaniga G, et al. Br J Haematol. 2002 Nov;119(2):445-53. doi: 10.1046/j.1365-2141.2002.03838.x. Br J Haematol. 2002. PMID: 12406084 Free article.

4

FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.

Arrigoni P, Beretta C, Silvestri D, Rossi V, Rizzari C, Valsecchi MG, Cazzaniga G, Biondi A. Arrigoni P, et al. Among authors: cazzaniga g. Br J Haematol. 2003 Jan;120(1):89-92. doi: 10.1046/j.1365-2141.2003.04032.x. Br J Haematol. 2003. PMID: 12492581 Free article.

5

Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL.

Cazzaniga G, d'Aniello E, Corral L, Biondi A. Cazzaniga G, et al. Best Pract Res Clin Haematol. 2002 Dec;15(4):623-38. doi: 10.1053/beha.2002.0228. Best Pract Res Clin Haematol. 2002. PMID: 12617867 Review.

6

Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia.

Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Aricò M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A. Tartaglia M, et al. Among authors: cazzaniga g. Blood. 2004 Jul 15;104(2):307-13. doi: 10.1182/blood-2003-11-3876. Epub 2004 Feb 24. Blood. 2004. PMID: 14982869 Free article.

7

Minimal residual disease as a surrogate marker for risk assignment to ALL patients.

Cazzaniga G, Gaipa G, Rossi V, Biondi A. Cazzaniga G, et al. Rev Clin Exp Hematol. 2003 Sep;7(3):292-323. Rev Clin Exp Hematol. 2003. PMID: 15024971 Review.

8

KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.

Beghini A, Ripamonti CB, Cairoli R, Cazzaniga G, Colapietro P, Elice F, Nadali G, Grillo G, Haas OA, Biondi A, Morra E, Larizza L. Beghini A, et al. Among authors: cazzaniga g. Haematologica. 2004 Aug;89(8):920-5. Haematologica. 2004. PMID: 15339674 Free article.

9

Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines.

Cittera E, Onofri C, D'Apolito M, Cartron G, Cazzaniga G, Zelante L, Paolucci P, Biondi A, Introna M, Golay J. Cittera E, et al. Among authors: cazzaniga g. Cancer Immunol Immunother. 2005 Mar;54(3):273-86. doi: 10.1007/s00262-004-0599-4. Epub 2004 Sep 23. Cancer Immunol Immunother. 2005. PMID: 15449038 Free PMC article.

10

Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.

Cazzaniga G, Biondi A. Cazzaniga G, et al. Haematologica. 2005 Mar;90(3):382-90. Haematologica. 2005. PMID: 15749670 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page